Your session is about to expire
← Back to Search
The Use of D-Cycloserine to Augment CBT for Pediatric OCD (DCS Trial)
Phase 2
Waitlist Available
Led By Lindsey Bergman
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment (study day 9)
Awards & highlights
Approved for 5 Other Conditions
All Individual Drugs Already Approved
Summary
This trial is testing whether a medication called D-cycloserine can make therapy more effective for children and teens with OCD. The medication is given before therapy sessions to help the brain learn that feared objects or situations are safe. Researchers hope this will improve treatment outcomes for kids who don't fully respond to standard therapy.
Eligible Conditions
- Obsessive-Compulsive Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-treatment (study day 9)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment (study day 9)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
OCD symptom severity on the Children's Yale Brown Obsessive Compulsive Scale (CYBOCS)
Awards & Highlights
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: DCSActive Control1 Intervention
Participant takes one pill of D-Cycloserine a day 4 times weekly immediately preceding the treatment session for two weeks of treatment (4 sessions weekly).
Group II: PlaceboPlacebo Group1 Intervention
Participant takes one pill of placebo a day 4 times weekly immediately preceding the treatment session for two weeks of treatment (4 sessions weekly).
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,567 Previous Clinical Trials
10,266,974 Total Patients Enrolled
10 Trials studying Obsessive-Compulsive Disorder
615 Patients Enrolled for Obsessive-Compulsive Disorder
Lindsey BergmanPrincipal InvestigatorUniversity of California, Los Angeles